Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.

CONCLUSIONS: To summarize, we identified a novel 14-gene immune-related signature that may potentially serve as a prognostic predictor for colorectal cancer, thereby contributing to patient personalized treatment decisions. Further research needs to be conducted to validate the prognostic value of the selected genes. PMID: 32096169 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32096169?dopt=Abstract

Source: European Review for Medical and Pharmacological Sciences - February 26, 2020 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research